We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
Turnover
16.03%
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+3.46%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$59.9B
AUM Growth
+$3.22B
(+5.7%)
Cap. Flow
+$2.93B
Cap. Flow
% of AUM
4.9%
Top 10 Holdings %
Top 10 Hldgs %
16.49%
Holding
2,255
New
142
Increased
870
Reduced
944
Closed
192
Avg Time Held
5.5
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fiserv Inc
FISV
|
+$366M |
| 2 |
Paychex
PAYX
|
+$275M |
| 3 |
Deckers Outdoor
DECK
|
+$233M |
| 4 |
Texas Instruments
TXN
|
+$218M |
| 5 |
Merck
MRK
|
+$200M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$202M |
| 2 |
Flutter Entertainment
FLUT
|
+$170M |
| 3 |
DexCom
DXCM
|
+$147M |
| 4 |
Nutanix
NTNX
|
+$135M |
| 5 |
DoorDash
DASH
|
+$134M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.62% |
| 2 | Healthcare | 15.45% |
| 3 | Financials | 12.81% |
| 4 | Consumer Discretionary | 11.42% |
| 5 | Industrials | 10.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1851
Addus HomeCare
ADUS
$2.18B
| $8.38K | ﹤0.01% |
78
-92
| -54% | -$10.6K |
2018 Q1
31 quarters
|
|
1852
Del Monte Corp
DMC
$1.41B
| $8.3K | ﹤0.01% |
+233
| New | +$8.31K |
2025 Q4
0 quarters
|
|
1853
Strata Critical Medical Inc
SRTA
$384M
| $8.04K | ﹤0.01% |
1,671
-1,795
| -52% | -$8.68K |
2025 Q2
2 quarters
|
|
1854
Corbus Pharmaceuticals
CRBP
$83.7M
| $7.97K | ﹤0.01% |
979
+6
| +0.6% | +$74 |
2025 Q1
3 quarters
|
|
1855
CareDx
CDNA
$3.45B
| $7.88K | ﹤0.01% |
+418
| New | +$7K |
2025 Q4
0 quarters
|
|
1856
Daily Journal
DJCO
$880M
| $7.8K | ﹤0.01% |
+16
| New | +$7.11K |
2025 Q4
0 quarters
|
|
1857
Red Robin
RRGB
$173M
| $7.55K | ﹤0.01% |
1,864
+112
| +6% | +$562 |
2025 Q3
1 quarter
|
|
1858
Q32 Bio
QTTB
$231M
| $7.55K | ﹤0.01% |
2,273
-101
| -4% | -$285 |
2024 Q3
5 quarters
|
|
1859
Diebold Nixdorf
DBD
$2.26B
| $7.54K | ﹤0.01% |
111
-65
| -37% | -$4.06K |
2025 Q3
1 quarter
|
|
1860
QuantumScape Corp
QS
$2.62B
| $7.35K | ﹤0.01% |
705
+56
| +9% | +$772 |
2022 Q3
13 quarters
|
|
1861
Vanguard Short-Term Corporate Bond ETF
VCSH
$44B
| $7.33K | ﹤0.01% |
+92
| New | +$7.34K |
2025 Q4
0 quarters
|
|
1862
Enact Holdings
ACT
$6.28B
| $7.33K | ﹤0.01% |
185
-1,849
| -91% | -$69.6K |
2023 Q3
9 quarters
|
|
1863
Richtech Robotics
RR
$320M
| $7.18K | ﹤0.01% |
+2,222
| New | +$9.82K |
2025 Q4
0 quarters
|
|
1864
Telephone and Data Systems
TDS
$3.92B
| $7.01K | ﹤0.01% |
171
-186
| -52% | -$7.25K |
2024 Q4
4 quarters
|
|
1865
Clover Health Investments
CLOV
$2.49B
| $6.91K | ﹤0.01% |
2,942
+308
| +12% | +$842 |
2025 Q3
1 quarter
|
|
1866
DELISTED
Terns Pharmaceuticals
TERN
| $6.83K | ﹤0.01% |
+169
| New | +$3.91K |
2025 Q4
0 quarters
|
|
1867
BP
BP
$125B
| $6.81K | ﹤0.01% |
196
| – | – |
2023 Q2
10 quarters
|
|
1868
DELISTED
Ventyx Biosciences
VTYX
| $6.75K | ﹤0.01% |
748
-3,948
| -84% | -$29.5K |
2025 Q1
3 quarters
|
|
1869
Herbalife
HLF
$1.53B
| $6.68K | ﹤0.01% |
+518
| New | +$5.49K |
2025 Q4
0 quarters
|
|
1870
Pilgrim's Pride
PPC
$6.88B
| $6.63K | ﹤0.01% |
170
-252
| -60% | -$9.69K |
2024 Q1
7 quarters
|
|
1871
Electromed
ELMD
$232M
| $6.61K | ﹤0.01% |
227
+127
| +127% | +$3.33K |
2024 Q2
6 quarters
|
|
1872
Globalstar
GSAT
$10.7B
| $6.59K | ﹤0.01% |
108
-45
| -29% | -$2.48K |
2025 Q3
1 quarter
|
|
1873
1stdibs.com
DIBS
$144M
| $6.58K | ﹤0.01% |
+1,098
| New | +$4.94K |
2025 Q4
0 quarters
|
|
1874
CleanSpark
CLSK
$2.4B
| $6.54K | ﹤0.01% |
646
-66,820
| -99% | -$1M |
2025 Q3
1 quarter
|
|
1875
DELISTED
Esperion Therapeutics
ESPR
| $6.35K | ﹤0.01% |
+1,716
| New | +$5.54K |
2025 Q4
0 quarters
|
|
Similar funds
Federated Hermes's Q4 2025 Portfolio in Review
As of Q4 2025, Federated Hermes held 2,255 positions worth $59.9B, up 5.7% from $56.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes deployed $2.93B of net new capital in Q4 2025, opening 142 new positions and adding to 870 existing holdings. Its largest new stake was Beta Technologies Inc: 1,075,413 shares worth $30.3M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Johnson & Johnson, an estimated $202M trimmed.
- Federated Hermes's largest Q4 2025 buy was Beta Technologies Inc: 1,075,413 shares worth $30.3M.
- Federated Hermes added most to Fiserv Inc in Q4 2025, an estimated $366M increase.
- Federated Hermes's biggest Q4 2025 reduction was Johnson & Johnson, cutting an estimated $202M.
- Federated Hermes fully exited Flutter Entertainment in Q4 2025, selling an estimated $170M.
- Federated Hermes's ten largest holdings make up 16% of its $59.9B portfolio in Q4 2025.
- Federated Hermes opened 142 new positions and closed 192 in Q4 2025.
- Federated Hermes's portfolio value rose 5.7% quarter-over-quarter to $59.9B.
Based on Federated Hermes's 13F filing for Q4 2025, filed 12 Feb 2026.